Navigation Links
MELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in the American Society of Dermatologic Surgery Annual Meeting

ommitted to raising awareness of the disease and helping dermatologists fight this deadly epidemic with MelaFind® as an advanced tool to help in diagnosis," said Robert Coradini, Interim CEO for MELA Sciences. "It is the only FDA approved and CE Marked optical diagnostic device for melanoma detection, which non-invasively and painlessly takes 3-D images of a mole as deep as 2.5mm below the skin's surface with multi-spectral light and analyzes 75 key features with proprietary algorithms to aid dermatologists with useful information in their biopsy decisions of ambiguous moles."

"The results obtained from a MelaFind® exam combined with my expertise in dermatology and knowledge of patient histories helps me to make the best decision for my patients when examining atypical lesions," said Darrell Rigel, MD, Clinical Professor of Dermatology, New York University and recently named Chief Medical Advisor to the Board of Directors of MELA Sciences, Inc. "Using MelaFind®, I can see up to 2.5mm beneath the surface of the skin to obtain information I wouldn't have seen using the naked eye."

MelaFind® has been recognized by the Cleveland Clinic as a Top 10 Medical Innovation for 2013 and was recently featured in The Wall Street Journal. Consumers can learn more about the device or locate a dermatologist with MelaFind® in their area by visiting

About MELA Sciences, Inc.
MELA Sciences, Inc. is a medical device company focused on the commercialization of its flagship product, MelaFind® and its further design and development. MelaFind® is a non-invasive tool that provides additional information to dermatologists during melanoma skin examinations. The device uses light from visible to near-infrared wavel

SOURCE MELA Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
2. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
3. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
4. Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine
5. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
6. Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference
7. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
8. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
9. Jaipal Reddy, Honble Minister of Science and Technology & Earth Sciences, Inaugurates the International Bioenergy Summit in Delhi
10. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
11. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
Post Your Comments:
(Date:4/27/2015)... 27, 2015 Dr. Robert Hanzlik, whose ... toxicity carries implications for advancing the creation of safer ... National University , the second-largest private, nonprofit university ... Hanzlik, a professor at the University of Kansas School ... design, starts at 5 p.m. and takes place at ...
(Date:4/27/2015)... April 27, 2015 ... please scroll to bottom . Investor-Edge ... Pharmaceuticals Inc. (NASDAQ: LXRX ), Idera Pharmaceuticals ... (NASDAQ: SNTA ), Spectrum Pharmaceuticals Inc. (NASDAQ: ... MDVN ). Free research report on Lexicon Pharma ...
(Date:4/27/2015)... and HEIDELBERG , Germany ... Addresses unmet need in treatment of millions of ... has been granted a patent in Europe ... patent supports Molecular Health,s discovery that EPHB4 is a novel ... promotes tumor growth. EPO stimulates the production of red blood ...
(Date:4/27/2015)... 2015 Diasome Pharmaceuticals, Inc. (“Diasome”) ... Joslin Diabetes Center (“Joslin”) to collaborate on the ... novel Hepatocyte Directed Vesicle (“HDV”) targeting system for ... , Located in Boston, Massachusetts, Joslin is the ... organization dedicated to the prevention, treatment and cure ...
Breaking Biology Technology:Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 2Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 3Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 2Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 3Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 4Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 5Molecular Health Gains Patent for Novel Receptor Utilizing Computational Biomarker Discovery Technology 2Diasome Pharmaceuticals Announces Clinical Trial Design Collaboration 2
... Imago Scientific Instruments has sold one of ... of Engineering for use in the new W.M. ... lab will be the primary research center of ISU's ... Narasimhan, an associate professor of chemical and biological engineering. ...
... has secured $5 million in a funding round led ... LLC. , ,The funding will allow Jellyfish to ramp up ... conjunction with the funding, retail industry veteran Ralph Dillon, managing ... of Directors. , ,Jellyfish has gained traction in online retailing ...
... research team at the Medical College of Wisconsin ... National Heart, Lung, and Blood Institute to support ... which was awarded to an investigative team led by pediatric ... molecular and clinical understanding of Von Willebrand disease ...
Cached Biology Technology:Online retailer lands $5M in funding 2Online retailer lands $5M in funding 3Medical College secures $9.7M research grant 2
(Date:4/9/2015)... Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the third quarter of ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-438-5524 (conference ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... the American Society of Tropical Medicine and Hygiene (ASTMH) -- ... bring together in one place global experts who are battling ... that each year kill or sicken hundreds of millions of ... medicine and global health will present new insights and research ...
... N.C. -- Recognizing that some of the leading ... are located in the Research Triangle Park area, ... $13.6 million grant to establish a multi-university center ... scientific endeavor. Researchers from Duke University, North ...
... Bethesda, MDA new commentary published online in The FASEB ... diligent and demand proof of safety and benefit before ... treatments have very little scientific evidence that they actually ... the article, Phillip J. Baker, Ph.D., Executive Director of ...
Cached Biology News:Latest on malaria, dengue, radiation threats, bedbugs, cholera in Haiti at ASTMH Annual Meeting 2Latest on malaria, dengue, radiation threats, bedbugs, cholera in Haiti at ASTMH Annual Meeting 3NSF establishes Triangle (NC) Center for Soft Matter Research 2NSF establishes Triangle (NC) Center for Soft Matter Research 3Chronic pain: Watch out before accepting diagnosis and treatment 2